Thursday, May 26, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

by Medical Finance
in Coronavirus
Study: SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection. Image Credit: Imilian/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

The rapid development and rollout of vaccines on a messenger ribonucleic acid (mRNA) platform, encoding the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent behind the ongoing coronavirus disease 2019 (COVID-19) pandemic, was heralded as a great step towards speeding up the end of the pandemic.


Study: SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection. Image Credit: Imilian/ShutterstockStudy: SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection. Image Credit: Imilian/Shutterstock


Two years later, the world is resigned to the prediction that the virus may not leave any time soon. This is due to the slow progress of vaccination in many developing or low-income regions and the rapid emergence of vaccine-antibody-resistant variants of the virus that can cause breakthrough infections in the fully vaccinated.


A new paper in the journal PLOS Pathogens discusses the appearance of quasi-species in a single host with prolonged infection, with different rates of infectivity and sensitivity to neutralization by antibodies elicited by the Pfizer vaccine or those present in convalescent plasma.


Background


The SARS-CoV-2 genome has mutated several times, and many of the mutations affect its transmissibility and/or neutralization by natural or vaccine-induced antibodies. The high-throughput sequencing of the viral genomes in many countries is a key tool in detecting and tracking such variants as Alpha, Beta, Gamma, Delta, and now Omicron.


The detection of resistance in several of these variants to neutralization by antibodies elicited by earlier variants has led to much research in this area since it threatens the scope for the production of a pan-coronavirus or pan-sarbecovirus vaccine that will be able to confer immunity against readily mutating RNA viruses.


Such research has benefited immensely from the use of single-genome sequencing (SGS) to understand the various quasi-species that are detected within a single host, how selective pressure within the host environment bears on their emergence and the differentiation of this pressure from that exerted by vaccine-induced antibodies and therapeutic or convalescent plasma antibodies.


This type of experiment showed the role of the escape mutations E484K, N501Y, or K417N/E484K spike mutations in promoting antibody escape by SARS-CoV-2. However, most of these studies occurred on highly infective variants, though immune-escape variants are typically less infective. The studies were also carried out on inter-individual variants.


In contrast, the current paper focuses on intra-individual variants found in the respiratory system of a single host.


What did the study show?


The intra-host variants were isolated from swabs taken from infected individuals, and the spike and nucleocapsid (S and N, respectively) genes were subjected to SGS. This approach yielded mostly unknown variants with reduced infectivity and with differing levels of resistance to the Pfizer vaccine and convalescent plasma.


The swabs came from nine infected individuals from various geographic locations and different ages. The samples showed high viral loads. On average, 44 viral genomes were sequenced per individual.


The results showed how intra-host variants developed at varying frequencies, from 6% in one case to almost a quarter of sequenced genomes in another. However, each variant existed in only a few copies. Some S mutations were found in multiple single-host variants from the same person, but only one was repeated in two individuals. One host yielded identical S gene sequences in all 46 viruses from the swab samples.


Deleterious S mutations were found in variants from three individuals and an escape mutation in one case. Two individuals carried variants with the same N-glycosylation site mutation and an O-glycosylation site mutation. None of these were due to the amplification process, as shown by the identical sequences obtained by applying SGS to 55 wild-type variants of the virus without detecting any mutations.


Compared with SGS, bulk sequencing missed most of the quasi-species, probably because the high-frequency variant is amplified much more than the less abundant variants. Some variants were also missed by SGS but appeared in variant calling analysis. However, SGS helped detect uncommon S variants that emerge over the time course of infection in one host but are not found, or found very rarely, in the current databases.


When the N gene, which is the most abundantly expressed within infected cells, and highly immunogenic, was sequenced, it was expected to show the effects of high immune selective pressure. From 142 N-gene sequences, multiple intra-host variants were detected, one of them being repeated in four of the five tested individuals. However, this was not found on the public database, like most of the other N variants identified.


In contrast, one synonymous substitution was reported in many isolates. Interestingly, the oldest individual in this study showed the greatest number of N variants, but not of S variants. This correlation deserves more study to tease out any connections between patient age, disease severity, and viral load with intra-host variation.


Some of the N variants were found to promote pseudovirus production and luciferase expression within infected cells, which may imply increased infectivity. Conversely, spike variants were mostly of low abundance. Ten selected spike mutants with different mutations were analyzed using pseudovirus assays with a luciferase reporter.


The results showed that all ten spike mutants were less infective than the wild-type spike-bearing variant. The S1 subunit F543S and S2 C840F mutations were associated with the greatest reduction in infectivity.


Again, two out of three spike variants from the infected participants showed high infectivity, comparable to wild-type virus, when incubated with convalescent plasma or vaccine-recipient serum. Both were confirmed to carry high levels of neutralizing immunoglobulin G (IgG) antibodies. The third showed reduced neutralization in 5/7 plasma samples from vaccinated individuals and both convalescent plasma samples.


What are the implications?


The results show that SARS-CoV-2 variants are present within a single host, but to a much lower extent than with the human immunodeficiency virus 1 (HIV 1), due to the strong proofreading process and the relatively short period of viral replication with the former. Even so, specific spike mutations were found that can reduce antibody binding and neutralization by natural or vaccine-induced antibodies. However, these mutations are also associated with reduced spread and perhaps deficient viral fitness.


As vaccination coverage extends over much wider regions, antibody-resistant variants will be selected, and these may become prevalent to a greater extent than at present, despite their reduced infectivity.


Conversely, N mutations were found to boost infectivity. The spike mutations associated with reduced infectivity should be mapped and may be useful in determining those sites on the virus that can be targeted to prevent viral replication.


Our findings shed light on SARS-CoV-2 adaptation to the human host and highlight the importance of mapping the landscape of SARS-CoV-2 intra-host variability for better evaluating variants of concern.”

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

by Medical Finance
May 26, 2022
0

The four free covid-19 rapid tests President Joe Biden promised in December for every American household have begun arriving in...

Nutritional components hold promise for improving the health and well-being of adults

New study helps explain the immune system’s response to skin infections and skin cancers

by Medical Finance
May 26, 2022
0

It is well established that older adults are more susceptible to infection and their immune systems less capable of generating...

Small cluster of neurons in the brain stem found to coordinate vocalization with breathing

Exits by Black and Hispanic teachers pose a new threat to covid-era education

by Medical Finance
May 26, 2022
0

Lynette Henley needed one more year to receive her full pension after 40 years as a teacher, but she couldn't...

Nearly 13% of the patients hospitalized for COVID-19 had serious neurologic symptoms

Nearly 13% of the patients hospitalized for COVID-19 had serious neurologic symptoms

by Medical Finance
May 26, 2022
0

Overwhelming evidence shows that infection with severe acute respiratory syndrome (SARS-CoV-2) causes dysfunction of multiple organ systems, including the nervous...

Study: DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study. Image Credit: Pikovit/Shutterstock

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

by Medical Finance
May 26, 2022
0

A survey conducted by a team of US-based scientists has recently demonstrated that patients with systemic autoimmune rheumatic diseases...

Study: Effect of oral nirmatrelvir on Long COVID symptoms: a case series. Image Credit: Donkeyworx / Shutterstock

Oral Nirmatrelvir’s effects on long COVID symptoms

by Medical Finance
May 26, 2022
0

In a recent study posted to the Research Square* preprint server, researchers at the University of California, San Francisco, examined...

Next Post
Study: Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants. Image Credit: GEMINI PRO STUDIO / Shutterstock.com

Immunity based upon “mild" Omicron infection is weak for Omicron reinfection

Study: Vaccine hesitancy and access to psoriasis care in the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. Image Credit: Fuss Sergey/Shutterstock.com

Study explores factors associated with COVID-19 vaccine hesitancy in individuals with psoriasis

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation. Image Credit: Kateryna Kon / Shutterstock.com
    Evidence of an increased risk of neurodegeneration after SARS-CoV-2 infection
  • Drug use and prohibited substances. Image Monika Gruszewicz A1 b3acfd6d2daf44ecbd36979af20eb378 620x480
    Researchers overcome key challenge in creating sulfur-based medicines
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply